ROSEN, LEADING TRIAL ATTORNEYS, Encourages Crocs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CROX

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Crocs, Inc. (NASDAQ: CROX) between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”), of the important March 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Crocs common stock during […]

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Newmont Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEM

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Newmont Corporation (NYSE: NEM) between February 22, 2024 and October 23, 2024, inclusive (the “Class Period”). A class action lawsuit has already been […]

ROSEN, A LONGSTANDING LAW FIRM, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – TGT

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Target Corporation (NYSE: TGT) between August 26, 2022 and November 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit […]

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end 2025- – Enrollment of Phase […]

Search

General News